MobiHealth News December 1, 2025
The partners are employing AI to identify undiagnosed and undertreated patients, support clinical trials and advance precision therapies.
Pangaea Data, a company focused on detecting patients with hard-to-diagnose diseases, is collaborating with pharma giant AstraZeneca to scale AI that helps identify and connect patients to clinical trials and existing therapies.
“Today marks an important milestone for Pangaea Data as we begin a new multi-year collaboration with AstraZeneca, supported by Microsoft and NVIDIA, to bring multimodal, clinical-grade AI into everyday care at scale,” Vibhor Gupta, founder and CEO of Pangaea Data, told MobiHealthNews.
The partnership follows Pangaea’s announcement in June of a collaboration with Alexion, AstraZeneca’s rare-disease unit, to co-develop and clinically validate an AI-enabled tool for detecting hypophosphatasia in adults,...
Today's Sponsors
Today's Sponsor